Tim De Groof! It’s not often when you get the best of both worlds - nano-bodies and #GPCRs.

April 2022 Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal (Strasbourg, France; CEO: Pascal Neuville; “Domain”) and Université de Montréal (Québec, Canada; “UdM

the Department of Biochemistry and Molecular Medicine of the Faculty of Medicine of the Université de

Timo De Groof About Dr. Timo De Groof Dr. Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and During his Ph.D., Timo, together with Dr. Timo De Groof on the web LinkedIn Researchgate Twitter Medical Imaging Group Google Scholar Dr.

Timo De Groof & Dr. JoAnn Trejo. Dr. GPCR Virtual Cafe : This month we are proud to present Dr. cholecystokinin A receptor Allosteric modulators enhance agonist efficacy by increasing the residence time interplay between pH receptors and immune cells: Potential drug targets Advances and challenges in time-resolved

Sponsors GPCR Retreat Program < Back to schedule Targeting adenosine signaling for immuno-oncology Date & Time Centre de Recherche du Centre Hospitalier de l'Université de Montréal; Faculté de Pharmacie. 900 St-Denis About John Stagg "John Stagg is a Professor of Pharmacy at Université de Montréal and researcher at the GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec